Original Research
Published on 21 Feb 2025
Time to initiation of antiresorptive agents in multiple myeloma to reduce skeletal related events
Frontiers in Hematology
doi 10.3389/frhem.2025.1521017
Volumes
120 Publications
Volume 4 - 2025
Original Research
Accepted on 14 Feb 2025
HPLC first approach in detecting thalassemia and other common hemoglobinopathies is more cost and time effective
Frontiers in Hematology
doi 10.3389/frhem.2025.1461498
- 135 views
Case Report
Accepted on 12 Feb 2025
Triplet combination with Pirtobrutinib/Venetoclax/Rituximab in Accelerated Phase of Chronic Lymphocytic Leukemia
Frontiers in Hematology
doi 10.3389/frhem.2025.1552200
- 156 views
Editorial
Accepted on 11 Feb 2025
Editorial: Hematopoietic Stress in Stem Cell Homeostasis and Disease Pathogenesis
Frontiers in Hematology
doi 10.3389/frhem.2025.1571674
- 128 views
Review
Accepted on 10 Feb 2025
Abnormalities of the primary and secondary hemostasis in multiple myeloma: insights from studies on thrombopoiesis, coagulation system, and bone marrow microenvironment
Frontiers in Hematology
doi 10.3389/frhem.2025.1435193
Mini Review
Published on 07 Feb 2025
The aging hematopoietic stem cell niche: a mini review
Frontiers in Hematology
doi 10.3389/frhem.2025.1525132
- 272 views
Case Report
Accepted on 04 Feb 2025
Acquired von Willebrand Disease associated with Smoldering Multiple Myeloma and Hereditary Hemorrhagic Telangiectasia successfully treated with Daratumumab, Pomalidomide, and Dexamethasone: Hitting three birds with one stone?case report
Frontiers in Hematology
doi 10.3389/frhem.2025.1499500
- 109 views
Original Research
Accepted on 04 Feb 2025
FACIT-Fatigue Scale in Patients with Cold Agglutinin Disease: Psychometric Validation and Estimation of Clinically Meaningful Change
Frontiers in Hematology
doi 10.3389/frhem.2025.1490130
Mini Review
Accepted on 03 Feb 2025
The role of Glucocorticoids in Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2025.1540152
Editorial
Published on 24 Jan 2025
Editorial: Two decades of targeted therapies in hematology: new targets and novel combinations
Frontiers in Hematology
doi 10.3389/frhem.2025.1548984
- 288 views
Volume 3 - 2024
Original Research
Published on 21 Jan 2025
Impact of leukemia subtype and demographics on patient quality of life in 76 countries: a cross-sectional study
Frontiers in Hematology
doi 10.3389/frhem.2024.1502166
- 1,362 views
Case Report
Published on 16 Jan 2025
Case report: VEXAS syndrome: first documented cases in Latin America
Frontiers in Hematology
doi 10.3389/frhem.2024.1501337
- 193 views
Case Report
Published on 10 Jan 2025
Case report: A decade-long journey with cyclic thrombocytopenia
Frontiers in Hematology
doi 10.3389/frhem.2024.1482891
- 212 views
Original Research
Published on 26 Dec 2024
Unique target binding by the C-terminal region of FHR1 provides a new perception of aHUS pathology
Frontiers in Hematology
doi 10.3389/frhem.2024.1469176
- 519 views
Mini Review
Published on 24 Dec 2024
Leveraging big data and artificial intelligence for smarter trials in myeloproliferative neoplasms
Frontiers in Hematology
doi 10.3389/frhem.2024.1504327
- 451 views
Case Report
Published on 17 Dec 2024
A patient with concurrent EBV-negative diffuse large B-cell lymphoma and angioimmunoblastic T-cell lymphoma: a case report
Frontiers in Hematology
doi 10.3389/frhem.2024.1463487
- 348 views